These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2875702)

  • 21. [Different effects of tricyclic (clomipramine and amitriptyline) and tetracyclic (maprotiline) antidepressors on the release of thyroid stimulating hormone, prolactin and growth hormone to thyrostimulating releasing hormone in patients with psychoaffective disorders (author's transl)].
    Schlienger JL; Kapfer MT; Singer L; Stephan F
    Acta Psychiatr Belg; 1980; 80(5):584-99. PubMed ID: 6786002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive methylphenidate response and blunted thyrotropin-releasing hormone response in depression.
    Schwarcz G; Halaris A; Gwirtsman H; Ahles S
    Am J Psychiatry; 1986 Mar; 143(3):397. PubMed ID: 3082222
    [No Abstract]   [Full Text] [Related]  

  • 23. Lithium therapy: from clinical trials to practical management.
    Coppen A; Abou-Saleh MT
    Acta Psychiatr Scand; 1988 Dec; 78(6):754-62. PubMed ID: 3146892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological treatment of delusional depression].
    Amore M; Giordani L; Giorgetti G; Zazzeri N
    Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The thyrotropin response to thyrotropin-releasing hormone as a predictor of response to treatment in depressed outpatients.
    Fava M; Rosenbaum JF; Birnbaum R; Kelly K; Otto MW; MacLaughlin R
    Acta Psychiatr Scand; 1992 Jul; 86(1):42-5. PubMed ID: 1414398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent neuroendocrine dysregulation in major depressive disorder: a marker for early relapse.
    Targum SD
    Biol Psychiatry; 1984 Mar; 19(3):305-18. PubMed ID: 6426529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The influence of lithium on the TRH test value in depressive patients (author's transl)].
    Höschl C
    Cesk Psychiatr; 1981 Apr; 77(2):116-9. PubMed ID: 6790180
    [No Abstract]   [Full Text] [Related]  

  • 29. Circadian effects on the TSH response to TRH in depressed patients.
    Duval F; Mokrani MC; Oliveira Castro J; Crocq MA; Andrade EE; Macher JP
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():384A-385A. PubMed ID: 1498884
    [No Abstract]   [Full Text] [Related]  

  • 30. Shortened REM latency as a psychobiological marker for psychotic depression? An age-, gender-, and polarity-controlled study.
    Stefos G; Staner L; Kerkhofs M; Hubain P; Mendlewicz J; Linkowski P
    Biol Psychiatry; 1998 Dec; 44(12):1314-20. PubMed ID: 9861474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
    Jäger M; Riedel M; Schmauss M; Pfeiffer H; Laux G; Naber D; Gaebel W; Huff W; Schmidt LG; Heuser I; Buchkremer G; Kühn KU; Rüther E; Hoff P; Gastpar M; Bottlender R; Strauss A; Möller HJ
    Psychiatry Res; 2008 Apr; 158(3):297-305. PubMed ID: 18280582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between vasopressin baseline and TSH-blunting in depressives.
    Lenzinger E; Meszaros K; Hornik K; Parzer P; Hollerer E; Langer G; Resch F; Legros JJ
    Biol Psychiatry; 1996 Mar; 39(5):341-5. PubMed ID: 8704065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylphenidate challenge as a predictor of relapse in schizophrenia.
    Lieberman JA; Kane JM; Gadaleta D; Brenner R; Lesser MS; Kinon B
    Am J Psychiatry; 1984 May; 141(5):633-8. PubMed ID: 6143506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How to manage depression and psychosis in Alzheimer's disease.
    Tueth MJ
    Geriatrics; 1995 Jan; 50(1):43-6, 49. PubMed ID: 7821828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paliperidone palmitate once-monthly reduces risk of relapse of psychotic, depressive, and manic symptoms and maintains functioning in a double-blind, randomized study of schizoaffective disorder.
    Fu DJ; Turkoz I; Simonson RB; Walling DP; Schooler NR; Lindenmayer JP; Canuso CM; Alphs L
    J Clin Psychiatry; 2015 Mar; 76(3):253-62. PubMed ID: 25562685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Simultaneous evaluation of the effects that change values of the thyreoliberin test in psychiatric patients].
    Höschl C; Roth Z
    Cas Lek Cesk; 1982 Apr; 121(16):481-8. PubMed ID: 6807546
    [No Abstract]   [Full Text] [Related]  

  • 37. Variability of response to lithium augmentation in refractory depression.
    Price LH; Charney DS; Heninger GR
    Am J Psychiatry; 1986 Nov; 143(11):1387-92. PubMed ID: 3096155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The thyrotropin-releasing hormone test may predict recurrence of clinical depression within ten years after discharge.
    Tsuru J; Ishitobi Y; Ninomiya T; Kanehisa M; Imanaga J; Inoue A; Okamoto S; Maruyama Y; Higuma H; Tanaka Y; Hanada H; Isogawa K; Akiyoshi J
    Neuro Endocrinol Lett; 2013; 34(5):409-17. PubMed ID: 23922049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroid indices and response to fluoxetine and nortriptyline in major depression.
    Gendall KA; Joyce PR; Mulder RT; Luty SE
    J Psychopharmacol; 2003 Dec; 17(4):431-7. PubMed ID: 14870956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J; Kaplan Z; Benjamin J
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.